Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis

被引:24
作者
Choi, Hee Jun [1 ]
Kim, Isaac [1 ]
Alsharif, Entad [1 ]
Park, Sungmin [1 ]
Kim, Jae-Myung [1 ]
Ryu, Jai Min [1 ]
Nam, Seok Jin [1 ]
Kim, Seok Won [1 ]
Yu, Jonghan [1 ]
Lee, Se Kyung [1 ]
Lee, Jeong Eon [1 ]
机构
[1] Sungkyunkwan Univ, Div Breast Surg, Dept Surg, Samsung Med Ctr,Sch Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Breast neoplasms; Lymph node excision; Neoadjuvant therapy; Sentinel lymph node biopsy; SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; CYTOLOGY-PROVEN; FEASIBILITY; ACCURACY; THERAPY; SURGERY;
D O I
10.4048/jbc.2018.21.e54
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to evaluate the effects of sentinel lymph node biopsy (SLNB) on recurrence and survival after neoadjuvant chemotherapy (NAC) in breast cancer patients with cytology-proven axillary node metastasis. Methods: We selected patients who were diagnosed with invasive breast cancer and axillary lymph node metastasis and were treated with NAC followed by curative surgery between January 2007 and December 2014. We classified patients into three groups: group A, negative sentinel lymph node (SLN) status and no further dissection; group B, negative SLN status with backup axillary lymph node dissection (ALND); and group C, no residual axillary metastasis on pathology with standard ALND. Results: The median follow-up time was 51 months (range, 3-122 months) and the median number of retrieved SLNs was 5 (range, 2-9). The SLN identification rate was 98.3% (234/238 patients), and the false negative rate of SLNB after NAC was 7.5%. There was no significant difference in axillary recurrence-free survival (p = 0.118), disease-free survival (DFS; p=0.578) or overall survival (OS; p=0.149) among groups A, B, and C. In the subgroup analysis of breast pathologic complete response (pCR) status, there was no significant difference in DFS (p=0.271, p=0.892) or OS (p=0.207, p=0.300) in the breast pCR and non-pCR patients. Conclusion: These results suggest that SLNB can be feasible and oncologically safe after NAC for cytology-determined axillary node metastasis patients and could help reduce arm morbidity and lymphedema by avoiding ALND in SLN-negative patients.
引用
收藏
页码:433 / 441
页数:9
相关论文
共 25 条
[1]   Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study [J].
Boileau, Jean-Francois ;
Poirier, Brigitte ;
Basik, Mark ;
Holloway, Claire M. B. ;
Gaboury, Louis ;
Sideris, Lucas ;
Meterissian, Sarkis ;
Arnaout, Angel ;
Brackstone, Muriel ;
McCready, David R. ;
Karp, Stephen E. ;
Trop, Isabelle ;
Lisbona, Andre ;
Wright, Frances C. ;
Younan, Rami J. ;
Provencher, Louise ;
Patocskai, Erica ;
Omeroglu, Atilla ;
Robidoux, Andre .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) :258-U150
[2]   Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial [J].
Boughey, Judy C. ;
Suman, Vera J. ;
Mittendorf, Elizabeth A. ;
Ahrendt, Gretchen M. ;
Wilke, Lee G. ;
Taback, Bret ;
Leitch, A. Marilyn ;
Kuerer, Henry M. ;
Bowling, Monet ;
Flippo-Morton, Teresa S. ;
Byrd, David R. ;
Ollila, David W. ;
Julian, Thomas B. ;
McLaughlin, Sarah A. ;
McCall, Linda ;
Symmans, W. Fraser ;
Le-Petross, Huong T. ;
Haffty, Bruce G. ;
Buchholz, Thomas A. ;
Nelson, Heidi ;
Hunt, Kelly K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14) :1455-1461
[3]   Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection [J].
Caudle, Abigail S. ;
Yang, Wei T. ;
Krishnamurthy, Savitri ;
Mittendorf, Elizabeth A. ;
Black, Dalliah M. ;
Gilcrease, Michael Z. ;
Bedrosian, Isabelle ;
Hobbs, Brian P. ;
DeSnyder, Sarah M. ;
Hwang, Rosa F. ;
Adrada, Beatriz E. ;
Shaitelman, Simona F. ;
Chavez-MacGregor, Mariana ;
Smith, Benjamin D. ;
Candelaria, Rosalind P. ;
Babiera, Gildy V. ;
Dogan, Basak E. ;
Santiago, Lumarie ;
Hunt, Kelly K. ;
Kuerer, Henry M. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (10) :1072-+
[4]   Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis [J].
DiSipio, Tracey ;
Rye, Sheree ;
Newman, Beth ;
Hayes, Sandi .
LANCET ONCOLOGY, 2013, 14 (06) :500-515
[5]   Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer [J].
Enokido, Katsutoshi ;
Watanabe, Chie ;
Nakamura, Seigo ;
Ogiya, Akiko ;
Osako, Tomo ;
Akiyama, Futoshi ;
Yoshimura, Akiyo ;
Iwata, Hiroji ;
Ohno, Shinji ;
Kojima, Yasuyuki ;
Tsugawa, Koichiro ;
Motomura, Kazuyoshi ;
Hayashi, Naoki ;
Yamauchi, Hideko ;
Sato, Nobuaki .
CLINICAL BREAST CANCER, 2016, 16 (04) :299-304
[6]   Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18 [J].
Fisher, B ;
Brown, A ;
Mamounas, E ;
Wieand, S ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Fisher, ER ;
Wickerham, DL ;
Wolmark, N ;
DeCillis, A ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2483-2493
[7]   Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients:: An approach to its validity [J].
Fraile, M ;
Rull, M ;
Julián, FJ ;
Fusté, F ;
Barnadas, A ;
Llatjós, M ;
Castellà, E ;
Gonzalez, JR ;
Vallejos, V ;
Alastrué, A ;
Broggi, MA .
ANNALS OF ONCOLOGY, 2000, 11 (06) :701-705
[8]   Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Clinically Node-Positive Breast Cancer after Neoadjuvant Chemotherapy: A Meta-Analysis [J].
Fu, Jian-Fei ;
Chen, Hai-Long ;
Yang, Jiao ;
Yi, Cheng-Hao ;
Zheng, Shu .
PLOS ONE, 2014, 9 (09)
[9]   Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy [J].
Hennessy, BT ;
Hortobagyi, GN ;
Rouzier, R ;
Kuerer, H ;
Sneige, N ;
Buzdar, AU ;
Kau, SW ;
Fornage, B ;
Sahin, A ;
Broglio, K ;
Singletary, SE ;
Valero, V .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) :9304-9311
[10]   Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy [J].
Kang, Young-Joon ;
Han, Wonshik ;
Park, Soojin ;
You, Ji ng ;
Yi, Ha Woo ;
Park, Sungmin ;
Nam, Sanggeun ;
Kim, Joo Heung ;
Yun, Keong Won ;
Kim, Hee Jeong ;
Ahn, Sei Hyun ;
Park, Seho ;
Lee, Jeong Eon ;
Lee, Eun Sook ;
Noh, Dong-Young ;
Lee, Jong Won .
BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) :473-480